
Taking an experimental weight loss drug is a bold choice, but one which has paid off for one YouTuber.
Over the past few years, several types of 'fat jab' have become a household name, thanks to celebs and influencers using them to show off a whole new figure.
The GLP-1 drugs were originally created as a medication to help treat diabetes, but it was soon found that they did more than their original purpose, and that the pounds were soon falling off.
As well as the big names like Ozempic, Mounjaro and Wegovy (which now also comes in an tablet form rather than an injection) there's a new product currently undergoing clinical testing.
Advert
It hasn't yet been approved, but fans are clamouring for it as it target three different hormones, rather than the usual one for the other jabs.
Despite the fact it hasn't been clinically approved yet or passed the trials, some people have managed to get a hold of it and have been showing off their results.

During clinical trials, it was found to lead to an average of 26.6 percent weight loss over 84 weeks, making it the strongest jab available.
The results can be very fast, and this is something YouTuber Dizzll TV.
He shared his own journey with Retatrutide, which he took for four weeks to see its impact on his overall health and weight.
He took the peptide as directed, and was able to see an 11-pound loss throughout the experiment, bringing his weight to 274.6lbs.
He explained how he had maintained a fitness routine and around ‘900-ish’ calories eaten throughout the days.
He said: “I dropped 11 lbs in four weeks, guys. So, almost three pounds per week over the last month. Feel free to clap for me. I appreciate that.”
Calling it 'amazing’, he said his starting form saw him at approximately 31.2 per cent body fat, ending at 28 to 29 per cent body fat.
He went on to flex his muscles, which showed some definition underneath his remaining weight, which wasn’t noticeable before the trial of one milligram of the dosage.
Dizzll explained the ‘shocking’ weight loss has been an incredible thing for him, which he noted was ‘unremarkable’ in terms of side effects and struggles.
But don’t take this as your sign to illegally procure the drug as the Medicines and Healthcare products Regulatory Agency (MHRA) have already noted there are several suspected side effects, such as nausea and sickness, but there’s also a risk to your health if purchasing it outside of its clinical trials.
Some initial results from one of the studies has been shared in the Lancet medical journal by the jab developers Eli Lilly, according to the Guardian.
Researchers involved in the study said: “Retatrutide demonstrated substantial reduction in body weight alongside glycaemic control and cardiometabolic risk factors, with a safety profile generally similar to other molecules with GLP-1 receptor agonist activity."
The study is the largest of its kind so far involving the new medication, and featured a randomised, placebo-controlled, double blind trial which involved 2,047 participants around the world.
LADbible reached out to Eli Lilly for comment.